A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)

Authors: Rheingold, S. R., Tasian, S. K., Whitlock, J. A., Teachey, D. T., Borowitz, M. J., Liu, X., Minard, C. G., Fox, E., Weigel, B. J., Blaney, S. M.

Source: BRITISH JOURNAL OF HAEMATOLOGY. 177(3):467-474

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN384059441&indx=1&recIds=ETOCRN384059441

First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium

Authors: Balis, F. M., Thompson, P. A., Mosse, Y. P., Blaney, S. M., Minard, C. G., Weigel, B. J., Fox, E.

Source: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 79(1):181-187

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN381785554&indx=1&recIds=ETOCRN381785554

A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)

Authors: Loh, M. L., Tasian, S. K., Rabin, K. R., Brown, P., Magoon, D., Reid, J. M., Chen, X., Ahern, C. H., Weigel, B. J., Blaney, S. M.

Source: PEDIATRIC BLOOD AND CANCER. 62(10):1717-1724

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN380162670&indx=1&recIds=ETOCRN380162670

Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group

Authors: Kim, A., Widemann, B. C., Krailo, M., Jayaprakash, N., Fox, E., Weigel, B., Blaney, S. M.

Source: PEDIATRIC BLOOD AND CANCER. 62(9):1562-1566

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN376162629&indx=1&recIds=ETOCRN376162629

Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: A report of the Children's Oncology Group

Authors: Burke, M. J., Ahern, C., Weigel, B. J., Poirier, J. T., Rudin, C. M., Chen, Y., Cripe, T. P., Bernhardt, M. B., Blaney, S. M.

Source: PEDIATRIC BLOOD AND CANCER. 62(5):743-750

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN369324327&indx=1&recIds=ETOCRN369324327

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group

Authors: Wagner, L. M., Fouladi, M., Ahmed, A., Krailo, M. D., Weigel, B., DuBois, S. G., Doyle, L. A., Chen, H., Blaney, S. M.

Source: PEDIATRIC BLOOD AND CANCER. 62(3):440-444

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN366284060&indx=1&recIds=ETOCRN366284060

Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: A report from the children's oncology group phase I consortium

Authors: Voss, S. D., Glade-Bender, J., Spunt, S. L., DuBois, S. G., Widemann, B. C., Park, J. R., Leary, S. E., Nelson, M. D., Adamson, P. C., Blaney, S. M.

Source: PEDIATRIC BLOOD AND CANCER. 62(1):45-51

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN362973154&indx=1&recIds=ETOCRN362973154

Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group

Authors: Weigel, B., Malempati, S., Reid, J. M., Voss, S. D., Cho, S. Y., Chen, H. X., Krailo, M., Villaluna, D., Adamson, P. C., Blaney, S. M.

Source: PEDIATRIC BLOOD AND CANCER. 61(3):452-456

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN345883536&indx=1&recIds=ETOCRN345883536

A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study

Authors: Fouladi, M., Stewart, C. F., Blaney, S. M., Onar-Thomas, A., Schaiquevich, P., Packer, R. J., Goldman, S., Geyer, J. R., Gajjar, A., Kun, L. E.

Source: JOURNAL OF NEUROONCOLOGY. 114(2):173-179

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN337259170&indx=1&recIds=ETOCRN337259170

A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study

Authors: Blaney, S. M., Tagen, M., Onar-Thomas, A., Berg, S. L., Gururangan, S., Scorsone, K., Su, J., Goldman, S., Kieran, M. W., Kun, L.

Source: PEDIATRIC BLOOD AND CANCER. 60(4):627-632

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN327191249&indx=1&recIds=ETOCRN327191249

Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study

Authors: Warwick, A. B., Malempati, S., Krailo, M., Melemed, A., Gorlick, R., Ames, M. M., Safgren, S. L., Adamson, P. C., Blaney, S. M.

Source: PEDIATRIC BLOOD AND CANCER. 60(2):237-241

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN323841133&indx=1&recIds=ETOCRN323841133

Vascular-targeted photothermal therapy of an orthotopic murine glioma model

Authors: Day, E. S., Zhang, L., Thompson, P. A., Zawaski, J. A., Kaffes, C. C., Gaber, M. W., Blaney, S. M., West, J. L.

Source: NANOMEDICINE -FUTURE MEDICINE-. 7(8):1133-1148

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN324130419&indx=1&recIds=ETOCRN324130419

Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001)

Authors: Blaney, S. M., Kocak, M., Gajjar, A., Chintagumpala, M., Merchant, T., Kieran, M., Pollack, I. F., Gururangan, S., Geyer, R., Phillips, P.

Source: JOURNAL OF NEUROONCOLOGY. 109(3):565-571

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN318124034&indx=1&recIds=ETOCRN318124034

Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children’s Oncology Group study

Authors: DuBois, S. G., Shusterman, S., Reid, J. M., Ingle, A. M., Ahern, C. H., Baruchel, S., Glade-Bender, J., Ivy, P., Adamson, P. C., Blaney, S. M.

Source: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 69(4):1021-1027

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN309656901&indx=1&recIds=ETOCRN309656901

A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group

Authors: Baruchel, S., Pappo, A., Krailo, M., Baker, K. S., Wu, B., Villaluna, D., Lee-Scott, M., Adamson, P. C., Blaney, S. M.

Source: EUROPEAN JOURNAL OF CANCER. 48(4):579-585

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN306896311&indx=1&recIds=ETOCRN306896311

Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: A Children's Oncology Group trial (P9962)

Authors: Potter, S. L., Berg, S., Ingle, A. M., Krailo, M., Adamson, P. C., Blaney, S. M.

Source: PEDIATRIC BLOOD AND CANCER. 58(3):362-365

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN305016207&indx=1&recIds=ETOCRN305016207

A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study

Authors: Jakacki, R. I., Bouffet, E., Adamson, P. C., Pollack, I. F., Ingle, A. M., Voss, S. D., Blaney, S. M.

Source: NEURO ONCOLOGY. 13(8):910-915

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN310015713&indx=1&recIds=ETOCRN310015713

Nanoshell-mediated photothermal therapy improves survival in a murine glioma model

Authors: Day, E. S., Thompson, P. A., Zhang, L., Lewinski, N. A., Ahmed, N., Drezek, R. A., Blaney, S. M., West, J. L.

Source: JOURNAL OF NEUROONCOLOGY. 104(1):55-63

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN296035838&indx=1&recIds=ETOCRN296035838

Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study

Authors: Rajagopal, M. U., Hathout, Y., MacDonald, T. J., Kieran, M. W., Gururangan, S., Blaney, S. M., Phillips, P., Packer, R., Gordish-Dressman, H., Rood, B. R.

Source: PROTEOMICS -WEINHEIM-. 11(5):935-943

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN286414149&indx=1&recIds=ETOCRN286414149

Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: A report from the Children's Oncology Group

Authors: Widemann, B. C., Arceci, R. J., Jayaprakash, N., Fox, E., Zannikos, P., Goodspeed, W., Goodwin, A., Wright, J. J., Blaney, S. M., Adamson, P. C.

Source: PEDIATRIC BLOOD AND CANCER. 56(2):226-233

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN284885476&indx=1&recIds=ETOCRN284885476